Promacta Approval Expanded to Kids With Rare Blood Disorder

U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children one year and older with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP).
Source

Please follow and like us:
Facebook
Facebook
TWITTER
Visit Us
INSTAGRAM

Leave a Comment